COMMUNIQUÉS West-GlobeNewswire

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2017 Results
22/03/2018
Revenue increased 442% and 188%, respectively, compared to the three and twelve month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz., March 22, 2018 (GLOBE [...]
iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results
22/03/2018
Fourth quarter total revenues increased 14% year-over-year; total revenues increased 22% excluding MRI asset sale Conference call today at 4:30 p.m. ET NASHUA, N.H., March 22, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ [...]
CareDx Reports Fourth Quarter and FY2017 Financial Results
22/03/2018
47 Transplantation Centers Offering AlloSure 9 Centers Enrolled in K-OAR BRISBANE, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, [...]
La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin II) in the United States
22/03/2018
SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that GIAPREZA™ (angiotensin II), injection for intravenous infusion, is now commercially available. In [...]
Title21’s CEO Lynn Fischer Shares Her Career Pivot into Healthcare Technology on THE MENTORS RADIO SHOW
22/03/2018
PLEASANTON, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Co-founder and CEO of Title21 Health Solutions ( www.Title21.com ) Lynn Fischer will share her purpose-driven career story on The MENTORS RADIO SHOW this weekend. [...]
CyberFuels, Inc. Announces Completion of GSA Application and award of CAGE number
22/03/2018
PALM BEACH, Fla., March 22, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions, Inc. (Pink Sheets:ECSL) wholly owned subsidiary CyberFuels is pleased to announce that it has completed the registration process for [...]
Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants®
22/03/2018
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development [...]
Sharecare CEO Jeff Arnold to Interview Walmart’s David Hoke at The Conference Board’s Employee Health Care Conference in San Diego
22/03/2018
ATLANTA, March 22, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced that its co-founder, chairman and CEO Jeff Arnold will interview [...]
IBA SA : TRANSPARENCY NOTIFICATION
22/03/2018
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, March 22, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it [...]
IBA SA : NOTIFICATION DE TRANSPARENCE
22/03/2018
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 22 mars 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
Novartis drug Tasigna® approved by FDA to treat children with rare form of leukemia
22/03/2018
Tasigna ® (nilotinib) approved for pediatric patients with newly diagnosed Ph+ CML-CP and children with Ph+ CML-CP resistant or intolerant to prior TKI therapy New indication approved under FDA Priority Review [...]
UPDATE: The Wall Street Investor Forum 26th Annual Investor Conference
22/03/2018
MIAMI, March 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced today that due to weather conditions, the Company was not able to attend the [...]
William Demant Holding A/S: Decisions of annual general meeting 2018
22/03/2018
Company announcement no 2018-04 22 March 2018 Annual general meeting Today, William Demant Holding A/S held its annual general meeting at the Company's premises, Kongebakken 9, 2765 Smørum, Denmark. All proposals put [...]
BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
22/03/2018
RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., March 22, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), today announced [...]
Vistin Pharma ASA : UPDATE ON THE ENERGY TRADING BUSINESS
22/03/2018
Oslo, Norway, 22 March 2018 On 16 March 2018, Vistin Pharma ASA ("Vistin Pharma" or the "Company") announced that it had hired Torbjørn Kjus and Kenneth Tveter to establish a new business area within energy trading. [...]
Vistin Pharma ASA : CONTEMPLATED PRIVATE PLACEMENT
22/03/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Ritter Pharmaceuticals Announces 1-for-10 Reverse Stock Split
22/03/2018
Los Angeles, California, March 22, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut [...]
Resolutions from the Annual General Meeting of Novo Nordisk A/S
22/03/2018
Bagsværd, Denmark, 22 March 2018 - Today, Novo Nordisk A/S held its Annual General Meeting, at which the following were adopted: Financial year 2017 and 2018 The Company's statutory Annual Report 2017. The actual [...]
Ogilvy CommonHealth Appoints Andrew Schirmer as CEO
22/03/2018
PARSIPPANY, N.J., March 22, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced the appointment of Andrew [...]

Pages